8-K
filed July 22, 2024, 7:59 PM ET
ticker LITS
CIK 0001262104
other material
confidence high
sentiment negative
materiality 0.95
Lite Strategy, Inc. (LITS): restructuring charge — MEI Pharma halts voruciclib, cuts workforce, CEO/CMO depart, evaluates wind-down
Lite Strategy, Inc.
- Board unanimously begins evaluation of strategic alternatives including transactions or orderly wind-down.
- Reduction-in-force commencing; clinical development of voruciclib discontinued.
- CEO David Urso and CMO Richard Ghalie step down Aug 1, 2024; CFO Justin File appointed Acting CEO.
- Expected restructuring charges of ~$5.8 million in Q1 fiscal 2025 for one-time employee termination costs.
- Charles Baltic steps down as Chairperson; Frederick Driscoll appointed as Chair.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
David M. Urso departed as President and Chief Executive Officer at Lite Strategy, Inc..
- Action
- leaving
- Role
- President and Chief Executive Officer
Exact text from the filing
David M. Urso, our President and Chief Executive Officer, and Richard G. Ghalie, M.D., our Chief Medical Officer, will be leaving the Company effective August 1, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Richard G. Ghalie departed as Chief Medical Officer at Lite Strategy, Inc..
- Action
- leaving
- Role
- Chief Medical Officer
Exact text from the filing
David M. Urso, our President and Chief Executive Officer, and Richard G. Ghalie, M.D., our Chief Medical Officer, will be leaving the Company effective August 1, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Frederick W. Driscoll was appointed as Chairperson of the Company at Lite Strategy, Inc..
- Action
- appointed
- Role
- Chairperson of the Company
Exact text from the filing
The Board has appointed Frederick W. Driscoll as Chairperson of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Justin J. File was appointed as Acting Chief Executive Officer at Lite Strategy, Inc..
- Action
- appointed
- Role
- Acting Chief Executive Officer
Exact text from the filing
The Board has appointed Justin J. File, age 53, currently the Company’s Chief Financial Officer and Secretary, to serve in the additional capacity of Acting Chief Executive Officer (“Acting CEO”), effective as of August 1, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles V. Baltic III departed as Chairperson of the Board at Lite Strategy, Inc..
- Action
- step down
- Role
- Chairperson of the Board
Exact text from the filing
Charles V. Baltic III, the current Chairperson of the Board, will also step down from the Board effective immediately.
View on SEC.gov
Restructurings & Charges
SEC 8-K Item 2.05/2.06
confidence 0.9
Lite Strategy, Inc. announced a restructuring with charges of approximately $5.8 million affecting the Company (reduction-in-force).
- Type
- restructuring
- Charge
- approximately $5.8 million
- Affected area
- the Company
- Headcount
- reduction-in-force
Exact text from the filing
the Company expects to incur personnel-related restructuring charges of approximately $5.8 million in connection with one-time employee termination costs, including severance and other benefits, which are expected to be recognized in the first quarter of fiscal 2025
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.